OIG: Drugmakers should disclose wholesale prices to CMS

04/27/2011 | Hill, The

Medicare could save $4.4 million each year by reducing reimbursement for drugs covered under Part B that have an average sale price at least 5% more than the wholesale price, according to an HHS Inspector General's report. The CMS responded by saying doing so would violate a court order against disclosing wholesale prices to the public.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care